Pharmacology: Ketorolac Trometamol is a potent analgesic agent of the non-steroidal anti-inflammatory class (NSAID). It performs by inhibiting prostaglandin biosynthesis and inhibiting cyclooxygenase enzyme. Administrations of Ketorolac Trometamol per oral, i.m. or i.v. are not distributed widely. More than 99% Ketorolac bound on plasma protein but not irreversible bound to ocular tissue. Approximately 90% of Ketorolac is excreted through urine in permanent form and less Ketorolac and its metabolite are excreted through feces.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
